Chia oil induces browning of white adipose tissue in high-fat diet-induced obese mice

Chia oil induces browning of white adipose tissue in high-fat diet-induced obese mice

Journal Pre-proof Chia oil induces browning of white adipose tissue in high-fat diet-induced obese mice Thamiris de Souza, Simone Vargas da Silva, Tha...

4MB Sizes 0 Downloads 69 Views

Journal Pre-proof Chia oil induces browning of white adipose tissue in high-fat diet-induced obese mice Thamiris de Souza, Simone Vargas da Silva, Thaís Fonte-Faria, Vany NascimentoSilva, Christina Barja-Fidalgo, Marta Citelli PII:

S0303-7207(20)30072-1

DOI:

https://doi.org/10.1016/j.mce.2020.110772

Reference:

MCE 110772

To appear in:

Molecular and Cellular Endocrinology

Received Date: 29 August 2019 Revised Date:

3 February 2020

Accepted Date: 24 February 2020

Please cite this article as: de Souza, T., Vargas da Silva, S., Fonte-Faria, Thaí., Nascimento-Silva, V., Barja-Fidalgo, C., Citelli, M., Chia oil induces browning of white adipose tissue in high-fat dietinduced obese mice, Molecular and Cellular Endocrinology (2020), doi: https://doi.org/10.1016/ j.mce.2020.110772. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier B.V.

1 1

Chia oil induces browning of white adipose tissue in high-fat diet-induced obese mice

2 3

Thamiris de Souza1, Simone Vargas da Silva2, Thaís Fonte-Faria2, Vany Nascimento-Silva2, Christina

4

Barja-Fidalgo2, Marta Citelli1

5 6

1

7

RJ, Brazil

8

2

Institute of Nutrition, Department of Basic and Experimental Nutrition, Rio de Janeiro State University,

Department of Cellular Biology, Rio de Janeiro State University, RJ, Brazil

9 10

Corresponding author: Dr. Marta Citelli, Department of Basic and Experimental Nutrition, Institute of

11

Nutrition, Rio de Janeiro State University, Rua São Francisco Xavier, 524, Laboratory of Nutrition

12

Biochemistry, Rio de Janeiro, 20550-900, RJ, Brazil Phone/Fax: +552122340679; e-mail:

13

[email protected]

2 14

Abstract

15

Previous research suggests that omega-3 fatty acids from animal origin may promote the browning of

16

subcutaneous white adipose tissue. We evaluated if supplementation with a plant oil (chia, Salvia

17

hispanica L.) rich in alpha-linolenic fatty acid (C18:3; ω-3) would promote browning and improve

18

glucose metabolism in animals subjected to an obesogenic diet. Swiss male mice (n= 28) were divided

19

into 4 groups: C: control diet; H: high-fat diet; HC: animals in the H group supplemented with chia oil

20

after reaching obesity; HCW: animals fed since weaning on a high-fat diet supplemented with chia oil.

21

Glucose tolerance, inflammatory markers, and expression of genes and proteins involved in the

22

browning process were examined. When supplemented since weaning, chia oil improved glucose

23

metabolism and promoted the browning process and a healthier phenotype. Results of this study

24

suggested that chia oil has potential to protect against the development of obesity-related diseases.

25 26 27

Keywords: browning; chia oil; obesity, alpha-linolenic acid

3 28

1. INTRODUCTION

29

Obesity is an important public health problem due to the severity of its associated comorbidities

30

and its high prevalence. This condition is characterized by the excessive accumulation of fat in adipose

31

tissue (World Health Organization, 2016). The different types of adipose tissue have important

32

implications for the pathogenesis and treatment of metabolic complications related to obesity. There are

33

two types of adipose tissue classified depending on embryonic origin: white adipose tissue (WAT) and

34

brown adipose tissue (BAT) (Luo and Liu 2016). WAT plays a key role in endocrine and metabolic

35

functions, as it participates in regulating energy homeostasis and insulin sensitivity (Rosen and

36

Spiegelman, 2014). BAT contains multiple mitochondria and its main function to maintain the central

37

body temperature in response to cold is regulated by uncoupling-1 protein (UCP-1) (Cannon and

38

Nedergaard, 2004).

39

Due to the increase in the number of mitochondria and to the acquisition of phenotypic

40

characteristics similar to those of BAT, adipocytes in the subcutaneous adipose tissue have been

41

described as beige adipocytes when they undergo a process called browning (Cannon and Nedergaard,

42

2004; Petrovic et al., 2010). In response to cold stress and treatment with agonists of peroxisome

43

proliferator-activated receptor-gamma (PPAR-γ) or β-adrenergic receptor, the development of beige

44

adipocytes is increased (Li et al., 2014; Ye et al., 2013). An abundance of beige adipocytes in white

45

adipose tissue results in improved glucose metabolism and obesity-related insulin resistance (Sidossis,

46

and Kajimura, 2015; Stanford et al., 2015). In addition, identifying new regulators that promote adipose

47

tissue energy expenditure and activity to oxidize metabolic substrates can provide key therapeutic

48

targets in obesity, diabetes, and dyslipidemia. Studies have shown that some dietary molecules may be

49

effective in potentiating BAT thermogenic functions and improving metabolism (Okla et al., 2017).

50

Some previous studies suggested that omega-3 polyunsaturated fatty acids from animal origin may

51

improve the remodeling and browning in subcutaneous WAT and thermogenic markers in BAT in mice

52

(Laiglesia et al., 2016; Lund et al., 2018; Bargut et al., 2016). However, the potential of a plant-derived

53

omega-3 fatty acid (alpha-linolenic acid; ALA; C18: 3 n-3) to induce the browning process needs to be

54

investigated.

55

Chia (Salvia hispanica L.) is an oleaginous seed whose oil is the richest known source of

56

omega-3 fatty acids (Cahill, 2003). On average, it contains about 64% ALA (Ayerza et al., 2002;

57

Álvarez-Chávez et al., 2008; Mohd Ali et al., 2012). In vivo and in vitro studies have confirmed the

58

beneficial effects of omega-3 fatty acid supplementation on lipid and glucose metabolism (Wang and

59

Huang, 2015; Fonte-Faria et al., 2019).

60

Previously, our group observed that chia oil supplementation in obese mice was able to reverse

61

metabolic syndrome by increasing the efficiency of insulin signaling, while also increasing lean mass

62

and reducing fat mass (Fonte-Faria et al., 2019). Therefore, considering the content of omega-3 fatty

63

acids present in chia oil, as well as their benefits to glycemic homeostasis, we aimed to test the

64

hypothesis that chia oil could potentially induce the browning process in subcutaneous WAT.

4 65

MATERIAL AND METHODS

66 67

2.1. Animals and diet protocol

68

The Animal Experimentation Ethics Committee of Rio de Janeiro State University approved the animal

69

procedures (authorization number: CEA 047/2013). Protocols were carried out in strict accordance with

70

the ethical standards of the Declaration of Helsinki of 1964. Swiss mice were obtained from animal

71

facilities of the Federal University of Minas Gerais (UFMG, Belo Horizonte, Brazil). The animals were

72

housed under controlled conditions of a 12-hour light/dark cycle, 60% humidity, ambient temperature of

73

(23 ± 1 °C), and free access to food and water. Male mice were divided according to diet: the control

74

group (n = 7) received a normocaloric diet (13% energy derived from fat) and group H received a high-

75

fat diet (45% energy derived from fat) for 130 days. The other two high-fat diet groups were

76

supplemented with chia oil (1.5% w/w) from day 21 to 130 (HCW) or from day 90 to 130 (HC). Details

77

of the diets are provided in a previously published study (Fonte-Faria et al., 2019). The complete

78

chemical composition of the chia oil has already been described by da Silva et al. (2016). Alpha

79

linolenic acid constitutes ~60% of its total fatty acids. The study published by Oh et al. (2010) was used

80

to define the length of time to be adopted while treating with chia oil, as well as to define the amount of

81

oil to be supplemented. Considering the total amount of omega-3 fatty acids used in the study by Oh et

82

al. (2010) as well as the fatty acid composition of chia oil, we established an intervention model using

83

chia oil to treat mice that became obese following the dietetic protocol of Silva et al. (2016). Chia oil

84

was included in the chow. Body weight, food intake, and caloric intake were measured during the

85

treatment period. Food consumption was measured by the amount that was left in each cage.

86

2.2 Intraperitoneal Glucose Tolerance Test

87

Prior to the glucose tolerance test, animals were fasted overnight for 10 ± 2 h and wrapped in a towel the

88

following morning to minimize stress. The baseline blood glucose measurements were performed using

89

a drop of tail blood. Subsequently, the animals received a glucose challenge (1 g/kg of body weight, i.p.)

90

followed by repeated sampling of blood glucose readings at 30, 60, 120, and 150 min. The glucose

91

measurements were taken using a handheld glucometer (Accu-Chek Roche®; Indianapolis, IN, USA).

92

2.3 Sample Collection

93

After completing each experiment, mice were euthanized by with drawing blood from the heart under

94

anesthesia with a mixture of ketamine (50 mg/kg) andxylazine (20 mg/kg). Subcutaneous adipose tissue

95

from the abdominal region was collected and transferred to tubes, snap frozen in liquid nitrogen, and

96

stored at −80 °C until RNA extraction, western blotting, and immunohistochemistry analysis.

97

2.4 Measurement of plasma cytokines

5 98

Serum levels of leptin, Tumor Necrosis Factor-alpha (TNF-α), Interleukin-6 (IL6), and Interleukin-10

99

(IL10)were measured using appropriate ELISA kits (Peprotech, Rocky Hill, NJ, USA; and Cayman

100

Chemical, Ann Arbor, MI, USA; respectively), following the manufacturer’s instructions.

101

2.4 Quantification of mRNA in adipose tissue

102 103

qRT-PCR was used for mRNA quantification and the primers used (GenOne Biotechnologies) shown in

104

Table 1 were used. Total adipose tissue RNA was extracted with the RNeasy Mini Kit (Qiagen, Hilden,

105

Germany) following the manufacturer's recommendations. Total RNA samples were initially quantified

106

on a BioDrop µLITE spectrophotometer by analyzing the absorbance at 260nm. The purity of the

107

extracted RNA was evaluated by measuring the A260/A280 ratio presented by the equipment software.

108

cDNA synthesis was performed from 1 µg of total RNA usinga High Capacity RNA-to-cDNA Kit

109

(Applied Biosystems, Foster City, CA, USA), according to the manufacturer's recommendations. The

110

samples were incubated at 37 °C for 60 minutes, then at 95 °C for 5 minutes. The cDNA synthesis

111

reaction was performed on a Veriti Thermal Cycler (Applied Biosystems, Foster City, CA, USA). Real-

112

time PCR analysis was performed on a 7500 Real-Time PCR Applied Biosystems (Applied Biosystems,

113

Foster City, CA, USA) instrument by measuring green fluorescence from SYBR Green to quantify the

114

amplicons. Standard PCR conditions were 95 °C for 5 minutes and 30 cycles at 95 °C (5 s) and 60 °C

115

(10 s), followed by generating a dissociation curve to identify the number of amplicons.

116 117

2.5 Quantification of miRNAs in adipose tissue

118 119

RNA was isolated from the subcutaneous adipose tissue usingan RNeasy Mini Kit Assay (Qiagen,

120

Hilden, Germany). MiRNA levels were measure using the Applied Biosystems 7500 Fast Real-Time

121

PCR System and the TaqMan MicroRNA Assay kit (Applied Biosystems, Foster City, CA, USA) after

122

performing reverse transcription with the TaqMan Transcription Reversion MicroRNA kit (Applied

123

Biosystems, Foster City, CA, USA). The reactions were performedin 96-well plates (MicroAmp Optical

124

96-Well Reaction Plate, Applied Biosystems, Foster City, CA, USA). The TaqMan assays used were

125

miRNAs 30b (mmu481432 miR), 196a (mmu481627 miR) and 494 (mmu478135 miR), according to the

126

manufacturer's instructions. U6 small RNA was used as an endogenous control for miRNA expression

127

analysis.

128 129

2.5 Immunohistochemistry

130 131

For immunohistochemistry, adipose tissues from animals were fixed in paraformaldehyde (4% w/v); and

132

paraformaldehyde (4% w/v) with sucrose (10% w/v) for 30 minutes in each solution. The tissues were

133

stored in phosphate buffered saline (PBS) with 20% (w/v) sucrose at 4°C until use. For the inclusion of

134

the tissue, the samples were embedded in paraffin and cut with a microtome. Then, the slides were

6 135

dewaxed in xylol and ethanol solution (1:1) three times for three minutes and hydrated in decreasing

136

concentrations of ethyl alcohol (95%, 70%, and 50%). Then, slideswere washed 4 times in PBS,

137

blocked, and permeabilized with PBS/bovine serum albumin (BSA) containing 5%/Triton-X 0.3%

138

solution for 1 hour, incubated with a specific anti-UCP1 primary antibody (D9D6X, Rabbit mAb

139

#14670, Cell Signaling Technology, Danvers, Massachusetts, EUA) or a DAPI primary antibody

140

(Sigma-Aldrich, St. Louis, Missouri, EUA) overnight. The slides were then washed six times with PBS

141

and incubated with specific secondary antibodies for 1 hour. The images were captured at 20X and 40X

142

magnification on an Olympus BX40 fluorescence microscope. Secondary antibodies for the respective

143

primary antibodies were used as negative controls. The images were scanned and processed using

144

ImageJ and Adobe Photoshop software.

145 146

2.6 Western blotting

147 148

Western blotting was performed with samples of subcutaneous adipose tissue. The protein concentration

149

was determined by using the BCA Protein Assay kit (Pierce Biotech, Rockford, USA). The samples

150

were then treated with 5X concentrated sample buffer (50 mM Tris HCl, pH 6.8, 1% SDS, 5% β-

151

mercaptoethanol, 20% glycerol, 0.001% bromophenol blue) for 5 minutes at 95 °C and then frozen.

152

Samples containing 20 µg of protein were separated by 10% SDS-containing polyacrylamide gel

153

electrophoresis (SDS-PAGE). A molecular weight standard was used to estimate protein sizein all gels

154

(Rainbow Molecular Weight Marker, Amersham Biosciences). The proteins were transferred to PVDF

155

membranes (Hybond P PVDF, Amersham Pharmacia Biotech) for 30 minutes using asemi-dry system

156

(BIO RAD, Hercules, CA, EUA). The membranes were incubated for 1 hour with blocking solution

157

containing 5% bovine serum albumin (BSA;Sigma-Aldrich, St. Louis, Missouri, EUA) and T-TBS

158

(0.1% Tween 20 in TBS), then incubated at 4 °C with rabbit anti-VDAC2 (catalog number: 47104;

159

1:500, Abcam, Cambridge, UK) or

160

Cambridge, UK). The membranes were washed with T-TBS and then incubated with the specific

161

secondary antibody conjugated to biotin (1:5000 1:10000, Santa Cruz Biotechnology, Dallas, Texas,

162

EUA) for 1 hour. The membranes were washed with T-TBS and incubated with peroxidase-conjugated

163

streptavidin (1:10,000, Zymed, San Francisco, California, USA) for 1 hour. Immunoreactive proteins

164

were visualized by ECL labeling using anECL Plus kit (Amersham Biosciences, Pittsburgh, PA) and

165

analyzed by ChemiDoc (Bio-Rad, Hercules, CA, EUA). Bands were quantified by densitometry using

166

Image J software (NIH, USA).

mouse anti-Actin (catalog number: 101173, 1:1000, Abcam,

167 168

2.7 Statistical analyses

169 170

The results were analyzed statistically using Kruskal–Wallis one-way analysis of variance. The results

171

were presented as mean ± standard error (SEM). Values of p <0.05 were considered to indicate statistical

7 172

significance. Data were analyzed using GraphPad Prism version 5.00 for Windows (GraphPad Software,

173

La Jolla, CA, USA).

174 175

2.

RESULTS

176 177

3.1 Characterization of the obesity model with chia oil supplementation

178 179

The high-fat diet promoted an increased percentage of body weight gain in animals when compared with

180

the control diet (Fig. 1A and 1B). Chia oil supplementation reduced the percentage of body weight gain

181

of animals only when presented after obesity was established (Fig. 1B). Taking the period between the

182

90th and 130th days of life as a basis, the energy intake of the HC group did not differ from the H group.

183

On the other hand, HCW group energy intake was significantly lower (Fig. 1C and 1D).

184 185

3.2 Chia oil supplementation changes the plasma concentration of leptin in obese mice

186 187

The plasma concentration of leptin was reduced in the group supplemented with chia oil since weaning

188

(HCW) when compared to the concentration in group H (Figure 2A), although the model of obesity used

189

in this study did not cause an increase in circulating leptin levels compared to levels in control. Plasma

190

concentrations of TNF-α, IL-6, and IL-10 did not differ among groups (Fig 2, B–D).

191 192

3.3 Chia oil supplementation improves glycemic response

193 194

The supplemented groups (HC and HCW) exhibited greater efficiency of glucose uptake since they

195

presented lower glycemia throughout the glucose tolerance test (Fig. 3A and C). Mice in the high-fat diet

196

(H) group exhibited increased fasting blood glucose. On the other hand, supplementation with chia oil

197

since weaning (HCW), reduced plasma fasting glucose levels. However, the same did not occur when

198

chia oil supplementation was initiated at 90 days of life, when obesity was already established (HC

199

group) (Fig. 3B).

200 201

3.4 Chia oil promotes browning of subcutaneous adipose tissue

202 203

The quantification of PPAR-ɤ mRNA in subcutaneous adipose tissue was higher in the groups receiving

204

chia oil (Fig. 4A). PGC1-α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) is a

205

transcriptional regulator that co-induces mitochondrial biogenesis by activating different transcription

206

factors. The groups that received chia oil exhibited increased expression of PGC 1-α mRNA (Fig. 4B).

207

UCP-1 is a protein found primarily in the mitochondria of brown adipose tissue and the browning

208

process usually increases its expression. In both chia oil-supplemented groups, UCP-1 mRNA

8 209

expression was higher when compared to that of group H (Fig. 4C). mTFA is a mitochondrial

210

transcription factor that also participates in mitochondrial genome replication. By using Kruskal–Wallis

211

one-way analysis of variance, we did not find any difference among the groups when evaluating mTFA

212

mRNA expression (Fig. 4D). However, when comparing pairs of groups instead of comparing all of

213

them (Mann–Whitney U test), we observed that the HC and HCW groups showed greater expression

214

than the H group (p<0.001), data not shown). HCW group exhibited greater levels of OPA-1 (Fig. 4E),

215

which is a gene encoding a protein that regulates mitochondrial fusion. We evaluated the expression of

216

carnitine palmitoyltransferase I (CPT-1), a mitochondrial marker and a key enzyme essential to the beta-

217

oxidation of long chain fatty acids, but we did not find any difference among the groups (Fig. 4F).

218

Subsequently, we quantified levels of miRNAs that are related to mitochondrial biogenesis process,

219

miR-196a, miR-30 and miR-494. No differences were observed among the groups (Fig. 4G, H, I).

220

Additionally, we analyzed the expression of the VDAC2 protein, which is a mitochondrial channel-

221

forming protein (porin) involved in cellular energy metabolism. Elevated VDAC2 expression was

222

observed in the HCW group (Fig. 5). The presence of UCP-1 in subcutaneous adipose tissue was also

223

observed by immunohistochemistry (Fig. 6). This result indicated a greater browning process in both

224

groups receiving chia oil, with a greater effect in the group that received chia oil since weaning.

225 226

4. Discussion

227

We identified molecular changes in the subcutaneous adipose tissue of obese animals promoted

228

by a plant oil supplementation. Regular ingestion of chia oil, the richest plant source of omega-3 fatty

229

acid, promoted the browning process. Browning of subcutaneous adipose tissue has been studied and

230

understood as a process capable of attenuating some of the effects of obesity (Langin, 2010). Here, we

231

identified increased expression of genes involved in mitochondrial biogenesis in subcutaneous adipose

232

tissue. Consistently, there was increased mitochondrial loading, as indicated by increased expression

233

of UCP-1 and VDAC proteins. EPA and DHA were previously associated with increased expression

234

of UCPs in multiple tissues, such as white and brown adipose tissues, liver, and muscle (Sadurskis et

235

al., 1995; Oudart et al., 1997; Baillie et al., 1999; Armstrong and Towle, 2001; Zhao and Chen, 2014).

236

Similar to the results of the present study, the Marineli et al. (2015) study showed that

237

prolonged treatment with chia seeds and short treatment with chia oil in obese animals restored the

238

expression of PGC1-α. In addition, treatment with fenofibrate (a PPAR-α agonist) is capable of

239

enhancing PGC1-α expression in the subcutaneous adipose tissue of animals, suggesting a central role

240

that this transcriptional regulator of mitochondrial biogenesis plays in the browning process (Rachid et

241

al., 2015).

242

On the other hand, we observed that supplementation with chia oil did not alter the expression

243

of miR-196a and miR-30, potential inducers of brown adipogenesis in white adipose tissue. They

9 244

represent promising targets for modulating the complex pathways and as potential regulators of

245

adipose tissue form and function, and the transcriptional programs that respond to ‘stress’ in adipose

246

tissue in obesity. MiR-196a seems to induce brown adipogenesis in human WAT and is upregulated in

247

inguinal WAT from mice exposed to cold or adrenergic stimulation (Mori et al., 2012; Schimanski et

248

al., 2009). Mice overexpressing miR-196a showed resistance to obesity and improved glucose

249

metabolism (Mori et al., 2012). Concurrently, the role of miR-30 in regulating thermogenesis was

250

previously described in vitro and in vivo. Overexpression of miR-30 greatly increased thermogenic

251

gene expression in primary subcutaneous white adipocytes (Hu et al., 2015). Considering the

252

involvement of miR 196 and 30 in the browning process, we evaluated these markers after

253

supplementation with chia oil. Additionally, we also evaluated the expression of miR-494 in the

254

adipose tissue since it is known to regulate mitochondrial biogenesis by downregulating mt-TFA in

255

skeletal muscle tissue (Yamamoto et al., 2012). It seems that these miR are not involved in the

256

browning process observed in the present study.

257

Here we showed that supplementation with chia oil after the establishment of obesity (HC group),

258

decreased the percentage of body weight gain. It has already been observed that omega-3 fatty acid

259

intake decreases the risk of body weight gain (Fonte-Faria et al., 2019). In contrast, when supplemented

260

with chia oil since weaning (HCW group), did not reduce the body weight gain. In the present study,

261

changes in body composition were not evaluated. However, it is possible that the supplementation

262

performed from weaning increased the percentage of lean mass, so that the body weight was not

263

changed overall. A previous study by our group found that supplementation with chia oil promoted an

264

increase in lean mass and decreased fat mass (Fonte-Faria et al., 2019).

265

The browning of WAT impact energy expenditure and glucose homeostasis. GPR120, a lipid-

266

sensitive G protein-coupled receptor (GPCR), may function as the omega-3 fatty acid receptor that

267

mediates its anti-inflammatory and insulin sensitizing effects. In addition, GPR120 has recently been

268

reported to influence BAT activation, especially the browning of subcutaneous WAT (Quesada-López

269

et al., 2016). Dietary enrichment with omega-3 PUFAs has beneficial effects on metabolic health in

270

healthy subjects and in individuals with metabolic disorders (Takahashi and Ide, 2000; Flachs et al.,

271

2011; Villarroya et al., 2014).

272

Here, plasma leptin levels were reduced in the HCW group, consistently with reduced energy

273

intake observed from the 90th to the 130th (Fig 1D). Surprisingly, animals fed a high-fat diet (H group)

274

did not show an increase in serum leptin concentrations, despite their weight gain. In our previous study

275

with a similar design (Fonte-Faria et al., 2019), using C57BL/6 instead of Swiss mice, we found an

276

increase in leptin levels in H group. Moreover, we found decreased leptin levels in HC group compared

277

to H group. Seeger and Murphy (2016) demonstrated the existence of differences in tissue fatty acid

278

uptake and trafficking between C57BL/6 and Swiss strains, highlighting its importance when carrying

279

out fatty acid metabolic studies.

280

Sundaram et al. (2016) compared high-fat diets with different amounts and sources of lipids and

281

observed that diets containing fish oil reduced the plasma concentration of leptin in mice. In humans,

10 282

dietary supplementation with EPA/DHA showed a negative correlation with plasma leptin

283

concentrations (Reseland et al., 2001). Furthermore, it has been described that one of the possible

284

benefits of omega-3 fatty acids is that they reduce levels of inflammatory adipokines, such as leptin.

285

However, when we investigated the concentrations of IL-10, an anti-inflammatory cytokine, we did not

286

identify any differences caused by chia oil supplementation. In addition, no changes were observed in

287

plasma concentrations of IL-6 or TNF-α. These data corroborate new studies that have been

288

questioning the association between inflammation and obesity. A study published by Kim et al. (2015)

289

showed that increased adipocyte size might lead to insulin resistance, regardless of inflammation. In

290

mice treated with clodronate (to deplete macrophages), a high-fat diet induced adipocyte hypertrophy

291

and caused insulin resistance independently of the activation of inflammatory response (Lee et al.,

292

2011).

293

The association of changes in glucose metabolism in response to excessive weight gain has

294

been widely discussed in the literature. Previously, we described changes in the insulin-signaling

295

pathway in response to chia oil supplementation (Fonte-Faria et al., 2019). In the present study,

296

animals supplemented with chia oil presented an improved glycemic response compared to animals

297

that did not receive chia oil.

298

Data from this study indicate that supplementation with chia oil induced the browning process

299

and was even more beneficial to health when supplemented from the beginning of obesity

300

development. Insulin resistance and diabetes mellitus are the main comorbidities of obese individuals.

301

Therefore, the data reinforce the benefits of using chia seed oil to prevent them.

302 303

Conflicts of interest: All authors stated that there were no conflicts of interest.

304 305

Acknowledgments: This study was funded by Fundação Carlos Chagas Filho de Amparo à Pesquisa do

306

Estado do Rio de Janeiro (FAPERJ; grants #E-26/010001754/2015, #E-26/202782/2017), Conselho

307

Nacional de Desenvolvimento Científico e Tecnológico (CNPq; grant #408401/2017-6). The authors

308

thank Genilson Silva for technical assistance.

309 310 311

References

312 Álvarez-Chávez, L. M., Valdivia-López, M. D. L. A., Aburto-Juarez, M. D. L., Tecante, A., 2008. 313

Chemical characterization of the lipid fraction of Mexican chia seed (Salvia hispanica L.). Int. J Food

314

Prop. 11(3), 687-697.

11 315 Armstrong, M. B., Towle, H. C., 2001. Polyunsaturated fatty acids stimulate hepatic UCP-2 expression via 316

a PPARα-mediated pathway. Am J Physiol Endocrinol Metab. 281(6), E1197-E1204.

317 Ayerza, R., Coates, W., Lauria, M., 2002. Chia seed (Salvia hispanica L.) as an omega-3 fatty acid source 318

for broilers: influence on fatty acid composition, cholesterol and fat content of white and dark meats,

319

growth performance, and sensory characteristics. Poult Sci. 81(6), 826-837.

320 Baillie, R. A., Takada, R., Nakamura, M., Clarke, S. D., 1999. Coordinate induction of peroxisomal acyl321

CoA oxidase and UCP-3 by dietary fish oil: a mechanism for decreased body fat deposition.

322

Prostaglandins Leukot Essent Fatty Acids. 60(5-6), 351-356.

323 Bargut, T. C. L., Martins, F. F., Santos, L. P., Aguila, M. B., Mandarim-de-Lacerda, C.A., 2019. 324

Administration of eicosapentaenoic and docosahexaenoic acids may improve the remodeling and

325

browning in subcutaneous white adipose tissue and thermogenic markers in brown adipose tissue in

326

mice. Mol Cell Endocrinol. 482, 18-27.

327 Bargut, T. C. L., Silva-e, A. C. A. G., Souza-Mello, V., Mandarim-de-Lacerda, C. A., Aguila, M. B., 2016. 328

Mice fed fish oil diet and upregulation of brown adipose tissue thermogenic markers. Eur J Nutr. 55(1),

329

159-169.

330 Cahill, J. P. (2003). Ethnobotany of chia, Salvia hispanica L.(Lamiaceae). Economic Botany 57(4), 604331

618.

332 Cannon, B., Nedergaard, J. A. N., 2004. Brown adipose tissue: function and physiological significance. 333

Physiol Rev. 84(1), 277-359.

334 da Silva, B. P., Anunciação, P. C., Matyelka, J. C. D. S., Della Lucia, C. M., Martino, H. S. D., Pinheiro335

Sant'Ana, H. M., 2017. Chemical composition of Brazilian chia seeds grown in different places. Food

336

Chem. 221, 1709-1716.

337 da Silva, S. V., Renovato-Martins, M., Ribeiro-Pereira, C., Citelli, M., Barja-Fidalgo, C., 2016. Obesity 338

modifies bone marrow microenvironment and directs bone marrow mesenchymal cells to adipogenesis.

339

Obesity. 24(12), 2522-2532.

340 Flachs, P., Rühl, R., Hensler, M., Janovska, P., Zouhar, P., Kus, V., et al., 2011. Synergistic induction of 341

lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie

342

restriction and n-3 fatty acids. Diabetologia, 54(10), 2626-38.

12 343 Fonte-Faria, T., Citelli, M., Atella, G. C., Raposo, H. F., Zago, L., de Souza, T, et al., 2019. Chia oil 344

supplementation changes body composition and activates insulin signaling cascade in skeletal muscle

345

tissue of obese animals. Nutrition, 58, 167-174.

346 Hu, F., Wang, M., Xiao, T., Yin, B., He, L., Meng, W., et al., 2015. miR-30 promotes thermogenesis and 347

the development of beige fat by targeting RIP140. Diabetes, 64(6), 2056-2068.

348 Kim, J. I., Huh, J. Y., Sohn, J. H., Choe, S. S., Lee, Y. S., Lim, C. Y., et al., 2015. Lipid-overloaded 349

enlarged adipocytes provoke insulin resistance independent of inflammation. Mol Cell Biol. 35(10),

350

1686-1699.

351 Laiglesia, L. M., Lorente-Cebrian, S., Prieto-Hontoria, P. L., Fernandez-Galilea, M., Ribeiro, S. M. R., 352

Sainz, N., et al., 2016. Eicosapentaenoic acid promotes mitochondrial biogenesis and beige-like features

353

in subcutaneous adipocytes from overweight subjects. J Nutr Biochem. 37, 76-82.

354 Langin, D., 2010. Recruitment of brown fat and conversion of white into brown adipocytes: strategies to 355

fight the metabolic complications of obesity? Biochim Biophys Acta. 1801(3), 372-376.

356 Lee, Y. S., Li, P., Huh, J. Y., Hwang, I. J., Lu, M., Kim, J. I., et al., 2011. Inflammation is necessary for 357

long-term but not short-term high-fat diet–induced insulin resistance. Diabetes, 60(10), 2474-2483.

358 Li, Y., Fromme, T., Schweizer, S., Schöttl, T., Klingenspor, M., 2014. Taking control over intracellular 359

fatty acid levels is essential for the analysis of thermogenic function in cultured primary brown and

360

brite/beige adipocytes. EMBO Rep, 15(10), 1069-1076.

361 Lund, J., Larsen, L. H., Lauritzen, L., 2018. Fish oil as a potential activator of brown and beige fat 362

thermogenesis. Adipocyte, 7(2), 88-95.

363 Luo, L., Liu, M., 2016. Adipose tissue in control of metabolism. J Endocrinol. 231(3), R77-R99. 364 Marineli, R. S., Moura, C. S., Moraes, E. A., Lenquiste, S. A., Lollo, P. C. B., Morato, P. N., et al., 2015. 365

Chia (Salvia hispanica L.) enhances HSP, PGC-1α expressions and improves glucose tolerance in diet-

366

induced obese rats. Nutrition, 31(5), 740-748.

367 Mohd Ali, N., Yeap, S. K., Ho, W. Y., Beh, B. K., Tan, S. W., Tan, S. G., 2012. The promising future of 368

chia, Salvia hispanica L. J Biomed Biotechnol. 2012: 171956.

369 Mori, M., Nakagami, H., Rodriguez-Araujo, G., Nimura, K., Kaneda, Y., 2012. Essential role for miR-196a 370

in brown adipogenesis of white fat progenitor cells. PLoS Biol. 10(4), e1001314.

13 371 Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., et al., 2010. GPR120 is an omega372

3 fatty acid receptor mediating potent anti-inflammatory and insulin sensitizing effects. Cell. 142(5),

373

687–98.

374 Okla, M., Kim, J., Koehler, K., Chung, S., 2017. Dietary factors promoting brown and beige fat 375

development and thermogenesis. Adv Nutr. 8(3), 473-483.

376 Oudart, H., Groscolas, R., Calgari, C., Nibbelink, M., Leray, C., Le Maho, Y., et al., 1997. Brown fat 377

thermogenesis in rats fed high-fat diets enriched with n-3 polyunsaturated fatty acids. Int J Obes Relat

378

Metab Disord. 21(11), 955.

379 Petrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., Nedergaard, J., 2010. Chronic 380

peroxisome proliferator-activated receptor γ (PPARγ) activation of epididymally derived white

381

adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes

382

molecularly distinct from classic brown adipocytes. J Biol Chem. 285(10), 7153-7164.

383 Quesada-López, T., Cereijo, R., Turatsinze, J. V., Planavila, A., Cairó, M., Gavaldà-Navarro, A., et al., 384

2016. The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes. Nat

385

Commun. 7, 13479.

386 Rachid, T. L., Penna-de-Carvalho, A., Bringhenti, I., Aguila, M. B., Mandarim-de-Lacerda, C. A., Souza387

Mello, V., 2015. Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white

388

adipose tissue from diet-induced male obese mice. Mol Cell Endocrinol. 402, 86-94.

389 Reseland, J. E., Haugen, F., Hollung, K., Solvoll, K., Halvorsen, B., Brude, et al., 2001. Reduction of leptin 390

gene expression by dietary polyunsaturated fatty acids. J Lipid Res. 42(5), 743-750.

391 Rosen, E. D., Spiegelman, B. M., 2014. What we talk about when we talk about fat. Cell, 156(1-2), 20-44. 392 Sadurskis, A., Dicker, A., Cannon, B., Nedergaard, J., 1995. Polyunsaturated fatty acids recruit brown 393

adipose tissue: increased UCP content and NST capacity. Am J Physiol. 269(2), E351-E360.

394 Schimanski, C. C., Frerichs, K., Rahman, F., Berger, M., Lang, H., Galle, P. R., et al., 2009. High miR395

196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol. 15(17),

396

2089-2096.

397 Seeger, D. R., Murphy, E. J., 2016. Mouse strain impacts fatty acid uptake and trafficking in liver, heart, 398

and brain: a comparison of C57BL/6 and Swiss Webster mice. Lipids. 51, 549–560.

14 399 Sidossis, L., Kajimura, S., 2015. Brown and beige fat in humans: thermogenic adipocytes that control 400

energy and glucose homeostasis. J Clin Invest. 125(2), 478-486.

401 Stanford, K. I., Middelbeek, R. J., Townsend, K. L., Lee, M. Y., Takahashi, H., So, K., et al., 2015. A novel 402

role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis.

403

Diabetes, 64(6), 2002-2014.

404 Sundaram, S., Bukowski, M. R., Lie, W. R., Picklo, M. J., Yan, L., 2016. High-fat diets containing different 405

amounts of n3 and n6 polyunsaturated fatty acids modulate inflammatory cytokine production in mice.

406

Lipids, 51(5), 571-582.

407 Takahashi, Y., Ide, T., 2000. Dietary n-3 fatty acids affect mRNA level of brown adipose tissue uncoupling 408

protein 1, and white adipose tissue leptin and glucose transporter 4 in the rat. Br J Nutr. 84(2), 175-184.

409 Villarroya, J., Flachs, P., Redondo-Angulo, I., Giralt, M., Medrikova, D., Villarroya, F., et al., 2014. 410

Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.

411

Lipids, 49(11), 1081-1089.

412 Wang, Y., Huang, F., 2015. N-3 polyunsaturated fatty acids and inflammation in obesity: local effect and 413

systemic benefit. Biomed Res Int. 2015:581469.

414 World Health Organization, 2016. World Health Organization obesity and overweight fact sheet. 415 Yamamoto, H., Morino, K., Nishio, Y., Ugi, S., Yoshizaki, T., Kashiwagi, A., Maegawa, H., 2012. 416

MicroRNA-494 regulates mitochondrial biogenesis in skeletal muscle through mitochondrial

417

transcription factor A and Forkhead box j3. Am J Physiol Endocrinol Metab. 303, E1419–E1427.

418 Ye, L., Wu, J., Cohen, P., Kazak, L., Khandekar, M. J., Jedrychowski, M. P., et al., 2013. Fat cells directly 419

sense temperature to activate thermogenesis. Proc Natl Acad Sci U S A. 110(30), 12480-12485.

420 Zhao, M., Chen, X., 2014. Eicosapentaenoic acid promotes thermogenic and fatty acid storage capacity in 421

mouse subcutaneous adipocytes. Biochem Biophys Res Commun.450(4), 1446-1451.

422 423

Figure captions

424

Figure 1: Body weight curve (A), Weight gain percentage (B), Energy intake (C), Energy intake from

425

90th to 130th day of life (D). C: control diet group (n = 7); H: high fat diet group (n = 7); HC: high-fat

426

diet supplemented with chia oil (n = 7); HCW: high-fat diet supplemented with chia oil since weaning (n

15 427

= 7). The arrows indicate the beginning of chia oil supplementation. The Kruskal–Wallis one-way

428

analysis of variance was used for statistical analysis. Data are expressed as mean ± SD and statistically

429

significant differences are set at P <0.05.

430 431

Figure 2: Plasma levels of leptin (A), TNF-alpha (B), IL-6 (C), and IL-10 (D) were analyzed by ELISA.

432

C: control diet group (n = 7); H: high fat diet group (n = 7); HC: high-fat diet supplemented with chia oil

433

(n = 7); HCW: high-fat diet supplemented with chia oil since weaning (n = 7). The Kruskal–Wallis one-

434

way analysis of variance was used for statistical analysis. Significance was considered for values of

435

P<0.05.

436 437

Figure 3: Glucose tolerance test (GTT) (A), fasting glycemia (B), and area under the GTT curve (C). C:

438

control diet group (n = 7); H: high-fat diet group (n = 7); HC: high-fat diet supplemented with chia oil (n

439

= 7); HCW: high-fat diet supplemented with chia oil since weaning (n = 7). The Kruskal–Wallis one-

440

way analysis of variance was used for statistical analysis. Significance was considered for values of

441

P<0.05.

442 443

Figure 4: Evaluation of mRNA levelsof genes encoding PPAR-ɣ (A), PGC-1α (B), UCP-1 (C), mTFA

444

(D), OPA1 (E), and CPT1a (F). Evaluation of expression for miR-196a (G), miR-30a (H) and miR-494

445

(I). C: control diet group (n = 5); H: high-fat diet group (n = 5); HC: high-fat diet supplemented with

446

chia oil (n = 5); HCW: high-fat diet supplemented with chia oil since weaning (n = 5). The Kruskal–

447

Wallis one-way analysis of variance was used for statistical analysis. Significance was considered for

448

values of P<0.05.

449 450

Figure 5: Western blot image of VDAC2 expression normalized to actin expression. C: control diet

451

group (n = 7); H: high-fat diet group (n = 7); HC: high-fat diet supplemented with chia oil (n = 7); HCW:

452

high-fat diet supplemented with chia oil since weaning (n = 7). Data are expressed as mean ± SD and

453

statistically significant differences are set at P <0.05. The Kruskal–Wallis one-way analysis of variance

454

was used for statistical analysis.

16 455

Figure 6: Immunohistochemical image with UCP-1 labeling. C: control diet group (n = 5); H: high-fat

456

diet group (n = 5); HC: high-fat diet supplemented with chia oil (n = 5); HCW: high-fat diet

457

supplemented with chia oil since weaning (n = 5).

458

Table 1. List of primers used for quantitative real-time PCR analysis. Gene

Forward (5' to 3')

Reverse (5' to 3')

GAPDH

ACAATGAATACGGCTACAGCAACAG

GGTGGTCCAGGGTTTCTTACTCC

PPARγ

GAGTGTGACGACAAGATTTG

GGTGGGCCAGAATGGCATCT

PGC1-α

AAGTGTGGAACTCTCTGGAACTG

GGGTTATCTTGGTTGGCTTTATG

UCP-1

AGATCTTCTCAGCCGGAGTTT

CTGTACAGTTTCGGCAATCCT

OPA-1

TGGAAAATGGTTCGAGAGTCAG

mTFA

CACCCAGATGCAAAACTTTCAG

CATTCCGTCTCTAGGTTAAAGC G CTGCTCTTTATACTTGCTCACAG

CPT1a

CTCAGTGGGAGCGACTCTTCA

GGCCTCTGTGGTACACGACAA

Table 1. Sequences of real-time PCR primers. GAPDH: glyceraldehyde-3-phosphate dehydrogenase; PPAR-γ: peroxisome proliferator-activated receptor-gamma; PGC-1α: peroxisome proliferator-activated receptor gamma coactivator 1-alpha; UCP-1: uncoupling-1 protein; OPA-1: mitochondrial dynamin like GTPase; mTFA: mithocondrial transcription factor; CPT1a: carnitinepalmitoyltransferase 1A

Highlights

Chia oil supplementation increases browning of subcutaneous adipose tissue. Obese animals treated with chia oil supplementation improves glucose metabolism. Chia oil supplementation is effective in treating obesity.